Investor Alert

New York Markets Open in:

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Sep 20, 2021, 4:24 a.m.

/zigman2/quotes/210324360/composite

$

304.80

Change

-2.10 -0.68%

Volume

Volume 121

Quotes are delayed by 20 min

/zigman2/quotes/210324360/composite

Previous close

$ 306.90

$ 306.90

Change

+7.02 +2.34%

Day low

Day high

$301.53

$310.69

Open

52 week low

52 week high

$138.00

$310.69

Open

Nicolas M. Barthelemy

Presently, Nicolas M. Barthelemy occupies the position of Executive Chairman at Biocare Medical LLC. Mr. Barthelemy is also on the board of 5 other companies.

In his past career he was Senior Project Engineer-Vaccine Technology at Merck & Co., Inc., Vice President-Manufacturing & General Manager at Biogen, Inc., General Manager of Research Triangle Park, President & Chief Executive Officer for Biotheranostics, Inc., President-Cell Systems Division at Invitrogen Corp. and President-Global Commercial Operations at Life Technologies Corp.

He received a graduate degree from the University of California, Berkeley and an undergraduate degree from École Supérieure de Physique et de Chimie de Paris.

Transactions

Date Shares Transaction Value
05/13/2021 457   Award at $0 per share. 0
11/09/2020 1,214   Disposition at $195.51 per share. 237,350
05/18/2020 3,009   Disposition at $142.53 per share. 428,873
05/18/2020 2,109   Derivative/Non-derivative trans. at $67.71 per share. 142,800
05/13/2020 527   Award at $0 per share. 0
04/22/2020 2,688   Disposition at $109.99 per share. 295,654
04/22/2020 1,652   Derivative/Non-derivative trans. at $42.07 per share. 69,499
04/03/2020 2,688   Disposition at $99.99 per share. 268,774
04/03/2020 1,652   Derivative/Non-derivative trans. at $42.07 per share. 69,499
05/15/2019 923   Award at $0 per share. 0
08/29/2018 6,580   Disposition at $54.44 per share. 358,216
08/29/2018 1,992   Derivative/Non-derivative trans. at $41.19 per share. 82,050
08/29/2018 2,434   Derivative/Non-derivative trans. at $38.76 per share. 94,341
05/16/2018 1,486   Award at $0 per share. 0
05/09/2018 26,500   Disposition at $40.54 per share. 1,074,310
05/09/2018 3,366   Derivative/Non-derivative trans. at $26.12 per share. 87,919
05/09/2018 24,000   Derivative/Non-derivative trans. at $20.37 per share. 488,880
05/18/2017 1,206   Award at $0 per share. 0

Officers and Executives

Mr. Tony J. Hunt
President, Chief Executive Officer & Director
Mr. James R. Bylund
Senior Vice President-Global Operations & IT
Mr. Jon K. Snodgres
Chief Financial Officer
Mr. Ralf Kuriyel
Senior Vice President-Research & Development
Mr. Kola Otitoju
Senior VP-Strategy & Business Development
Mr. Squire J. Servance
Secretary, Chief Compliance Officer & Senior VP
Mr. Steve Curran
Vice President-Global Operations
Mr. Vikas Gupta
Vice President-Chromatography
Ms. Christine Gebski
Senior VP-Filtration & Chromatography
Mr. Stephen Tingley
Vice President-Sales
Ms. Rachel Goodrich
Vice President-Marketing
Ms. Sondra S. Newman
Global Head-Investor Relations
Mr. Ken Elmer
Global Head-Human Resources
Ms. Karen T. Dawes
Chairman
Dr. Rohin Mhatre
Independent Director
Ms. Carrie Eglinton Manner
Independent Director
Mr. Thomas F. Ryan
Independent Director
Mr. Nicolas M. Barthelemy
Independent Director
Mr. Glenn P. Muir
Independent Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.